Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,206,326 papers from all fields of science
Search
Sign In
Create Free Account
Hydrocortisone butyrate
Known as:
11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate
, hydrocortisone 17-butyrate
, hydrocortisone-17-butyrate
Expand
The butyrate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
31 relations
Adrenal gland hypofunction
Congenital adrenal hyperplasia
Decreased Protein Synthesis [PE]
Dermatomycoses
Expand
Broader (2)
Dermatologic Agents
Hydrocortisone
Narrower (1)
Locoid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Pilot study of patient satisfaction with nonfluorinated topical steroids compared with a topical immunomodulator in atopiform dermatitis
C. Burkhart
,
C. Burkhart
International Journal of Dermatology
2004
Corpus ID: 25028423
Background There is clinical uncertainty concerning the effectiveness of the new topical immunomodulators vs. the conventional…
Expand
2000
2000
Contact sensitization to corticosteroids: increased risk in long term dermatoses.
M. Corazza
,
L. Mantovani
,
C. Maranini
,
S. Bacilieri
,
A. Virgili
EJD. European journal of dermatology
2000
Corpus ID: 13163081
Patients affected by chronic dermatoses are at high risk for the development of sensitization to corticosteroids. This study was…
Expand
1992
1992
Incidence of allergic reactions to hydrocortisone-17-butyrate in standard patch test series.
A. Lauerma
,
L. Förström
,
S. Reitamo
Archives of Dermatology
1992
Corpus ID: 23662984
To the Editor.— The number of cases published on contact allergy to topical corticosteroids has increased rapidly in the past few…
Expand
1988
1988
Influence of fatty acid-alcohol esters on percutaneous absorption of hydrocortisone butyrate propionate.
Y. Ozawa
,
T. Yamahira
,
H. Sunada
,
T. Nadai
Chemical and pharmaceutical bulletin
1988
Corpus ID: 37423279
Transcutaneous drug absorption is influenced by the physicochemical properties of both the drug and the vehicle. The effect of…
Expand
1985
1985
Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole…
J. Serup
,
P. Holm
Dermatologica
1985
Corpus ID: 23580987
Five corticosteroid ointments and placebo were compared in 17 volunteers with regard to their influence on normal skin under…
Expand
1980
1980
A randomized, double-blind therapeutic trial of 0.25% desoxymethasone and 0.1% hydrocortisone 17-butyrate in the treatment of varicose eczema.
M. Henry
,
G. Hanks
,
A. Whelan
Current Medical Research and Opinion
1980
Corpus ID: 3012536
A double-blind, randomized trial was carried out in 60 patients with varicose (hypostatic) eczema to compare the efficacy and…
Expand
1979
1979
Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double-blind comparison.
A. Lassus
Current Medical Research and Opinion
1979
Corpus ID: 35140847
Forty patients with symmetrical eczematous lesions on their extremities were treated in a double-blind fashion with 0.05…
Expand
1976
1976
Topical and systemic effects of hydrocortisone 17-butyrate.
J. Wieriks
,
W. Hespe
,
K. D. Jaitly
,
B. L. van Kan
Dermatologica
1976
Corpus ID: 36869042
In a series of hydrocortisone 17-esters, hydrocortisone 17-butyrate (HC-17B) has almost optimal lipophilicity resulting in a…
Expand
1976
1976
Comparison of desoximetasone and hydrocortisone butyrate in psoriasis.
H. Zachariae
Acta Dermato-Venereologica
1976
Corpus ID: 28264595
Thirty psoriatics were treated for 2 weeks on a double-blind controlled basis with desoximetasone (0.25%) and with hydrocortisone…
Expand
1973
1973
Adrenal suppression with topical hydrocortisone butyrate.
J. Hendrikse
,
A. Moolenaar
Dermatologica
1973
Corpus ID: 29647381
Hydrocortisone butyrate, when used topically in large quantities, can lead to suppression of the pituitary-adrenal system. This…
Expand